| Gene symbol | CD5 | Synonyms | LEU1, T1 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD5 molecule | ||||
| GTO ID | GTC2481 |
| Trial ID | NCT04594135 |
| Disease | T-Cell Acute Lymphoblastic Leukemia | T-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD5 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD5 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies |
| Year | 2020 |
| Country | United States |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG190-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||